Characteristics Associated with Upper-Range Doses of Beta-Blockers and Angiotensin-Renin Inhibitors in Reduced Ejection Fraction.
CONCLUSIONS: Achieving upper-range doses of ACE-Is/ARBs and BBs in HFrEF outpatients in a treatment up-titration program were associated with greater BMI and DM, respectively. These findings may serve as benchmarks for up-titration programs.
PMID: 32692500 [PubMed - as supplied by publisher]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
More News: Beta-Blockers | Cardiology | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | General Medicine | Heart | Heart Failure | Israel Health | Middle East Health | Obesity | Women